Neoplasms. Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Control group: citalopram tablets, 20- 40 milligram per day (adjusted based on the patient tolerance and treatment response), for 12 weeks. Intervention 2: Intervention group: Besides
Treatment - Drugs
Behavior
Control group: citalopram tablets, 20- 40 milligram per day (adjusted based on the patient tolerance and treatment response), for 12 weeks
Intervention group: Besides citalopram tablets (20-40 milligram per day) will participate in group cognitive behavioral psychotherapy classes. These group- therapy sessions are held weekly, free in
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: Breast cancer in the stage III or more; HADS score equals or more than 11 which can be due to symptomatic major depression; informed consent of the patient for participation in the study Exclusion criteria: severe psychiatric disorders such as psychosis or substance abuse; severe neurologic diseases; mental retardation; endocrine disorders
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: 3th, 6th and 12th weeks. Method of measurement: WHO Quality of Life Questionnaire (WHO-QOL BREF).;Severity of depression in the patient. Timepoint: 3th, 6th and 12th weeks. Method of measurement: Hospital Anxiety and Depression Scale (HADS). | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of suicidal attempts. Timepoint: 3th, 6th and 12th weeks. Method of measurement: self-report questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSussan Moudi
Babol University of Medical Sciences
Outcome results
None listed